Drug class
Third-generation cephalosporin beta-lactam antibacterial; antipseudomonal agent
Mechanism of action
Inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins and disrupting peptidoglycan cross-linking. It has activity against susceptible Gram-negative organisms including Pseudomonas aeruginosa; susceptibility varies by strain and resistance mechanisms.
General use cases
- Treatment of serious infections caused by ceftazidime-susceptible organisms, including selected lower respiratory-tract, urinary-tract, skin/soft-tissue, intra-abdominal, bone/joint, septicaemia and CNS infections; use should be guided by culture results and local antimicrobial guidance
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
